Edan Instruments, Inc.

Equities

300206

CNE100001252

Advanced Medical Equipment & Technology

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 07/06/2024 am IST			5-day change	1st Jan Change
9.18 ^CNY	+0.66%		-3.77%	-10.09%

25/04	Edan Instruments, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
29/03	Edan Instruments, Inc. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on May 6, 2024	CI

Tranche Update on Edan Instruments, Inc.'s Equity Buyback Plan announced on February 9, 2021.

January 04, 2022 at 09:30 pm IST

From October 1, 2021 to December 31, 2021, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 2,126,600 shares, representing 0.37% for CNY 30 million under the buyback announced on February 9, 2021.

Latest news about Edan Instruments, Inc.

Edan Instruments, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04	CI
Edan Instruments, Inc. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on May 6, 2024	29/03	CI
Edan Instruments, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03	CI
Edan Instruments, Inc. Focus on Medical Technology Advancement Shines At Medica 2023	14/11	CI
Edan Instruments, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	24/23/24	CI
Edan Instruments, Inc. Strengthens its APAC Business Landscape with Thailand Office Launch	01/23/01	CI
Edan Instruments, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	22/23/22	CI
Edan Instruments, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/23/26	CI
Edan Instruments, Inc. Announces Final Cash Dividend for the Year 2022, Payable on 28 April 2023	22/23/22	CI
Edan Instruments, Inc. Approves Cash Dividend for the Year 2022	21/23/21	CI
Edan Instruments, Inc. Proposes Final Cash Dividend for the Year 2022	29/23/29	CI
Edan Instruments, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	28/23/28	CI
Edan Instruments, Inc. Establishes Peru Office, Edan Diagnostics Peru S.A.C. in Lima	13/23/13	CI
Edan Instruments, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022	25/22/25	CI
Edan Instruments, Inc. Showcases Its First Molecular Diagnostics Analysis System, ClariLight CL30, at Medlab Asia & Asia Health 2022	19/22/19	CI
Edan Instruments, Inc. Reports Earnings Results for the Half Year Ended June 30, 2022	23/22/23	CI
Edan Instruments, Inc. Launches i20	26/22/26	CI
Edan Instruments, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	26/22/26	CI
Edan Instruments, Inc. Announces Cash Dividend for the Year 2021, Payable on 29 April 2022	23/22/23	CI
Edan Instruments, Inc. Approves Distribution for 2021	22/22/22	CI
Edan Instruments, Inc. Announces Appointment of Zheng Quanlu as Independent Director and Zhou Yirong as Non-Employee Supervisors	22/22/22	CI
Edan Instruments Slashes Final Dividend on Lackluster 2021 Earnings	25/22/25	MT
Edan Instruments, Inc. Announces Profit Distribution Proposal for the Year 2021	25/22/25	CI
Edan Instruments, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	23/22/23	CI
Tranche Update on Edan Instruments, Inc.'s Equity Buyback Plan announced on February 9, 2021.	08/22/08	CI

Chart Edan Instruments, Inc.

Duration

Period

More charts

Company Profile

Edan Instruments, Inc. is a China-based company principally engaged in the research, development, manufacture, sales of medical electronic equipment products and in-vitro diagnostic products, as well as the provision of related services. The Company provides maternity product series, including doppler fetal heart beat monitors, ultrasonic doppler fetal heart beat monitors, fetal/maternal monitors and maternity integrated diagnostic monitoring systems; electrocardiograph series, including digital twelve-channel electrocardiographs, digital six-channel electrocardiographs, electrocardiographic workstations, single-channel electrocardiographs and multi-channel electrocardiographs; monitoring product series, including portable multi-variable monitors, central monitoring systems and oximeters, as well as ultrasonic image product series, including digital ultrasonic diagnostic systems and others. The Company is also involved in the spare parts sale and in vitro diagnostics products business.

Sector

Advanced Medical Equipment & Technology

Calendar

23/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
EDAN INSTRUMENTS, INC.	-10.09%	734M
THERMO FISHER SCIENTIFIC	+9.48%	222B
DANAHER CORPORATION	+13.72%	195B
INTUITIVE SURGICAL, INC.	+23.79%	148B
BOSTON SCIENTIFIC CORPORATION	+33.39%	113B
SIEMENS HEALTHINEERS AG	+4.75%	66.45B
EDWARDS LIFESCIENCES CORPORATION	+15.59%	53.11B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+3.16%	50.03B
AGILENT TECHNOLOGIES, INC.	-4.35%	38.8B
GE HEALTHCARE TECHNOLOGIES INC.	-1.27%	34.85B

Other Advanced Medical Equipment & Technology